弥散加权MRI在急性缺血性卒中中的诊断准确性、时间窗评估及预后价值:一项系统综述与荟萃分析。
完整摘要 · 中文译文
背景:弥散加权成像(DWI)是急性缺血性卒中(AIS)管理的核心;然而,其在不同临床应用中的表现存在差异。本系统综述和荟萃分析全面评估了DWI在AIS中的诊断准确性、时间窗估计能力和预后价值。 方法:本注册系统综述检索了三大数据库,纳入2010年至2025年发表的关于成人AIS患者DWI研究的文献。采用QUADAS-2评估偏倚风险。荟萃分析分为三个不同阶段进行:(1)诊断准确性,(2)时间窗估计,(3)采用双变量随机效应模型评估预后价值。进行了广泛的亚组分析以探讨异质性来源,包括人工智能辅助、MRI场强、研究设计、发病至DWI时间、序列类型、病变位置和卒中严重程度。 结果:在34项符合条件的研究中,22项独立研究共30个数据集被纳入三个阶段的荟萃分析。DWI表现出优异的诊断准确性,合并敏感度为0.912(95% CI:0.888-0.932),特异度为0.959(95% CI:0.940-0.970)。在时间窗估计方面,DWI表现出中等性能,合并敏感度为0.786(95% CI:0.688-0.860),特异度为0.727(95% CI:0.668-0.780),存在显著异质性,且在后循环卒中中准确性明显较低。DWI衍生生物标志物在预测功能结局方面表现出良好的预后价值,合并敏感度为0.702(95% CI:0.540-0.825),且 特异度为0.904(95% CI:0.821-0.951)。 结论:DWI对AIS具有极佳的诊断准确性(敏感度:0.912,特异度:0.959),但用于时间估计的表现仅为中等(敏感度:0.786,特异度:0.727)。DWI衍生的生物标志物显示出良好的预后价值(敏感度:0.702,特异度:0.904),而人工智能和超快速MRI协议在提高临床实用性方面展现出前景。 研究设计:按照PRISMA指南注册的系统综述和荟萃分析 PROSPERO注册号:2026 CRD420261376477。
完整摘要 · 英文原文
BACKGROUND: Diffusion-weighted imaging (DWI) is central to acute ischemic stroke (AIS) management; however, its performance varies across different clinical applications. This systematic review and meta-analysis comprehensively evaluated the diagnostic accuracy, time window estimation capability, and prognostic value of DWI in AIS. METHODS: This registered systematic review searched three major databases for DWI studies in adult AIS patients published from 2010 to 2025. Risk of bias was assessed using QUADAS-2. The meta-analysis was performed in three distinct phases: (1) diagnostic accuracy, (2) time window estimation, and (3) prognostic value using a bivariate random-effects model. Extensive subgroup analyses were conducted to investigate sources of heterogeneity, including AI assistance, MRI field strength, study design, onset-to-DWI time, sequence type, lesion location, and stroke severity. RESULTS: Of 34 eligible studies, 22 independent studies with 30 datasets were included in the meta-analysis across three phases. DWI demonstrated excellent diagnostic accuracy with a pooled sensitivity of 0.912 (95% CI: 0.888-0.932) and specificity of 0.959 (95% CI: 0.940-0.970). For time window estimation, DWI showed moderate performance with a pooled sensitivity of 0.786 (95% CI: 0.688-0.860) and specificity of 0.727 (95% CI: 0.668-0.780), with substantial heterogeneity and markedly lower accuracy in posterior circulation strokes. DWI-derived biomarkers demonstrated good prognostic value for predicting functional outcomes with a pooled sensitivity of 0.702 (95% CI: 0.540-0.825) and specificity of 0.904 (95% CI: 0.821-0.951). CONCLUSION: DWI offers excellent diagnostic accuracy for AIS (sensitivity: 0.912, specificity: 0.959) but only modest performance for time estimation (sensitivity: 0.786, specificity: 0.727). DWI-derived biomarkers show good prognostic value (sensitivity: 0.702, specificity: 0.904), while AI and ultra-fast MRI protocols demonstrate promise for improving clinical utility. STUDY DESIGN: Registered systematic review and meta-analysis following PRISMA guidelines PROSPERO REGISTRATION: 2026 CRD420261376477.